Small cell breast carcinoma. Case report

Author:

Leszczyńska P.1,Sobocińska M.1,Ustymowicz K.2,Romańczyk W.

Affiliation:

1. Department of General Pathomorphology, Medical University of Bialystok, Poland

2. Medical University of Warsaw, Poland

Abstract

Introduction: Primary small cell breast carcinomais a highly malignant, uncommon cancer, whichaccounts for less than 1% of all breast cancers. It isusually found in women over 60 years of age as apalpable tumour of the breast or armpit. Due to thesmall number of relevant case reports, this type ofcancer presents a diagnostic and therapeuticchallenge.Case presentation: A 85-year-old woman showedup at the Oncology Clinic with a palpable node in theleft breast. On physical examination, the patient wasin general good condition, ECOG performancestatus of 1. In deviations from the norm, there was apalpable tumour with a diameter of ca. 4cm in thelower outer quadrant, 4 o'clock position of the leftbreast; and an enlarged, movable left axillary lymphnode, with a diameter of about 3 cm. The diagnosis,strongly influenced by the abovementioned tests,was small cell breast cancer TNBC-cT2N1M0. Asagreed at the case conference meeting, the patientwas qualified for neoadjuvant chemotherapyaccording to the 4-EP scheme, followed bymastectomy with lymphadenectomy of the leftarmpit and complementary radiotherapy. The patientreceived four courses of chemotherapy from 28March to 30 May 2023. The visible tumourregression in physical examination revealed goodtreatment tolerance – a reduction of tumour size onpalpation by half. The patient is undergoing followup checks after chemotherapy and awaits ascheduled surgery.Conclusions: Literature on primary small cell breastcarcinoma is still limited . Diagnostics of SCNCBinclude positron emission tomography (PET) and CTscans to rule out metastases from another primarylocation. Clinical treatment of SCNCB is stillunderdeveloped. A particularly important prognosticfactor is the size of tumour at the time of treatment.Early detection and interdisciplinary therapies maybe relevant for improving prognosis. Research on thediagnosis, treatment and prognosis of SCNCB is stillongoing.

Publisher

Index Copernicus

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3